CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 75-95% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

3M to take $5.8 billion hit under PFAS personal injury settlement

By Reuters News

Nov 3 (Reuters) - Industrial conglomerate 3M MMM.N said on Tuesday it had entered into a broad resolution to settle PFAS "forever chemicals" -related personal injury claims, and warned of a pre-tax hit of $5.8 billion in the fourth quarter.

Here are some more details:

  • Under the agreement, 3M would make a pre-tax $7.35 billion nominal commitment over nine years, with a present value of $5.8 billion

  • 3M said the resolution addressed about 99% of current personal injury claims inside and outside the Aqueous Film-Forming Foam Multi-District Litigation (AFFF MDL), involving about 115,000 to 120,000 plaintiffs eligible to participate, including all personal injury claims that had been the focus of the litigation

  • The payment structure includes a $50 million payment in 2026 and no payments in 2027, with about 20% of payments due in the final two years

  • 3M said it announced in 2022 that it would discontinue the manufacture of all PFAS globally by the end of 2025 and had successfully met that goal

  • "This settlement is a significant milestone for 3M and substantially reduces litigation uncertainty," CEO William Brown said in a statement on Tuesday

  • 3M said the charge does not change its previously issued 2026 forecast

  • The company said the agreement was not an admission of liability and would be prepared to continue to defend itself if the agreed settlement terms are not fulfilled

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.